The enclosed article published by NPS  discusses the new drug Pasireotide Diaspartate for Cushings Disease. ‘Cushing’s disease is caused by pituitary adenomas which secrete adrenocorticotrophic hormone (ACTH). Surgical treatment helps most patients, but some do not enter remission and others relapse. Pasireotide is an option for these patients and is also indicated for those who cannot have surgery. Pasireotide is given by subcutaneous injection preferably into the abdomen or top of the thigh. ‘

Pasireotide diaspartate PDF